A true theranostic pair - <sup>44/47</sup>Sc-labeled GRPR antagonist shows great promise for managing prostate and breast cancer. [PDF]
Kumar N +11 more
europepmc +1 more source
A long-lived impact-generated hydrothermal system at the Chicxulub impact structure. [PDF]
Pickersgill AE +17 more
europepmc +1 more source
Enhancing shielding efficiency of ordinary and barite concrete in radiation shielding utilizations. [PDF]
Ahmad N +5 more
europepmc +1 more source
[68Ga]Ga-DOTAGA-Glu(FAPi)2 Shows Enhanced Tumor Uptake and Theranostic Potential in Preclinical PET Imaging. [PDF]
Mortensen JVK +8 more
europepmc +1 more source
161Tb-PSMA radioligand therapy in prostate cancer: current evidence and future perspectives. [PDF]
Xiao L +7 more
europepmc +1 more source
Predictive factors of oral mucositis in patients with locally recurrent inoperable head and neck cancer treated with boron neutron capture therapy. [PDF]
Mälkiä T +7 more
europepmc +1 more source
Preclinical evaluation of DOTAGA.Glu.(FAPI)2 and DO3A.Glu.(FAPI)2 as theranostics with human dosimetry extrapolation to lutetium-177 and terbium-161 analogs. [PDF]
Bilinska A +8 more
europepmc +1 more source
Effect of Neutron Radiation on <sup>10</sup>BPA-Loaded Melanoma Spheroids and Melanocytes. [PDF]
Szczepanek M +7 more
europepmc +1 more source
Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the 68Ga- and 177Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)2. [PDF]
Läppchen T +9 more
europepmc +1 more source
Site-Selective Modification of Lanthanum Oxychloride to Modulate Halide-Ion Conduction. [PDF]
Cheng J +8 more
europepmc +1 more source

